Astrazeneca (AZN) Cash & Equivalents Growth (3y) (2012 - 2026)
Powered by 
Analysis
Astrazeneca (AZN) Cash & Equivalents Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Asml Holding | 618.78 Bn | 602.80 Bn | 5.90 Bn | 27.88% |
| 2 | Hsbc Holdings | 362.62 Bn | 362.62 Bn | - | - |
| 3 | General Electric | 329.79 Bn | 320.45 Bn | 6.95 Bn | -9.88% |
| 4 | Astrazeneca | 253.78 Bn | 248.49 Bn | 12.86 Bn | -4.76% |
| 5 | Citigroup | 228.38 Bn | -2,073.93 Bn | 24.75 Bn | - |
| 6 | Bhp | 216.07 Bn | 197.52 Bn | - | 14.25% |
| 7 | Rio Tinto | 203.71 Bn | 199.33 Bn | - | -0.98% |
| 8 | Diageo | 197.09 Bn | 195.06 Bn | - | -5.49% |
| 9 | Unilever | 139.31 Bn | 132.28 Bn | - | 0.34% |
| 10 | Hdfc Bank | 117.84 Bn | 80.69 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.76% |
| Mar 31, 2026 | 6.65% |
| Dec 31, 2025 | -2.52% |
| Sep 30, 2025 | 22.24% |
| Jun 30, 2025 | 13.58% |
| Mar 31, 2025 | -3.18% |
| Dec 31, 2024 | -4.64% |
| Sep 30, 2024 | -12.12% |
| Jun 30, 2024 | -23.70% |
| Mar 31, 2024 | 0.89% |
| Dec 31, 2023 | -9.32% |
| Sep 30, 2023 | -15.50% |
| Jun 30, 2023 | -0.05% |
| Mar 31, 2023 | 22.23% |
| Dec 31, 2022 | 4.72% |
| Sep 30, 2022 | 3.97% |
| Jun 30, 2022 | -3.90% |
| Mar 31, 2022 | 11.69% |
| Dec 31, 2021 | 66.73% |
| Sep 30, 2021 | 27.37% |